Clarendon Fund Managers

BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.

BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.

See.Sense is a company that specializes in developing innovative cycling technology aimed at enhancing rider safety and convenience. Its award-winning products utilize patented sensor technology and artificial intelligence to provide cyclists with insights and data that improve their riding experience and help them navigate safe routes. With over 50,000 cyclists using its products globally, See.Sense serves as the official bike light and ride insights supplier for British Cycling and Cycling Ireland. The unique data generated by its technology supports smart city initiatives, enabling urban planners to enhance cycling infrastructure, reduce congestion, and improve overall mobility within cities. The company designs and manufactures its products in Northern Ireland and has received multiple awards for business excellence, design, and innovation.

BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.

See.Sense is a company that specializes in developing innovative cycling technology aimed at enhancing rider safety and convenience. Its award-winning products utilize patented sensor technology and artificial intelligence to provide cyclists with insights and data that improve their riding experience and help them navigate safe routes. With over 50,000 cyclists using its products globally, See.Sense serves as the official bike light and ride insights supplier for British Cycling and Cycling Ireland. The unique data generated by its technology supports smart city initiatives, enabling urban planners to enhance cycling infrastructure, reduce congestion, and improve overall mobility within cities. The company designs and manufactures its products in Northern Ireland and has received multiple awards for business excellence, design, and innovation.

BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.

Autism Biotech is a company focused on developing a biochemical test for the early and reliable diagnosis of autism spectrum disorder. Its primary product, ASDtect, utilizes patented peptide biomarkers to detect autism from a simple blood sample. This innovative approach aims to address a significant and underserved market by facilitating timely intervention for those affected by autism. Currently headquartered in Belfast, Northern Ireland, Autism Biotech is in the process of conducting trials to validate its diagnostic test, with plans to make ASDtect available in the near future. By enabling healthcare professionals to identify autism earlier, the company seeks to improve treatment options and outcomes for patients.

Kelsius is a provider of automation technology focused on product safety and compliance for the food services and healthcare sectors. Established in 2003 and headquartered in Donegal, Ireland, the company specializes in wireless temperature monitoring systems and digital HACCP management solutions. Kelsius's technology enhances product safety and ensures adherence to regulatory standards while also optimizing costs related to these processes. By reducing product wastage linked to refrigeration failures and improving food quality, Kelsius empowers its clients to achieve significant cost savings and labor efficiencies through automation.

PathXL is a Northern Ireland-based company specializing in digital pathology image analysis, workflow software, and educational tools. The company develops software solutions aimed at enhancing image analysis and workflow management for the pathology field. Its technology is particularly beneficial for research and educational applications within the pathology and biopharma markets. By improving the quality of diagnoses and facilitating the review and sharing of extensive clinical data, PathXL's offerings support pathologists in their critical role in diagnosing and treating various diseases, including cancer. Through its innovative tools, the company contributes to better patient outcomes and the advancement of new therapies.